Priorix 0,5 ml Powder and diluent for solution for injection.
PDF Leaflet Revision Date: 27 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation against measles, mumps, and rubella.
Dosage (summary)
Single 0.5 ml dose, subcutaneous or intramuscular injection.
Special Populations
- Immunocompromised
- History of allergic diseases
Pregnancy & Breastfeeding
Contraindicated in pregnancy; caution in breastfeeding.
Key Drug Interactions
- Human gammaglobulins
- Blood transfusions
Contraindications
- Active untreated tuberculosis
- Blood dyscrasias
- Hypersensitivity to neomycin
- Immunodeficiency
- Pregnancy
Common side effects
- Fever
- Redness at injection site
- Upper respiratory tract infection
Counselling Points
- Monitor for allergic reactions
- Avoid pregnancy for 1 month post-vaccination
- Do not mix with other vaccines
Serious warnings
- Risk of anaphylaxis
- Syncope may occur
- Postpone in acute febrile illness
Important Disclaimer
The Priorix 0,5 ml Powder and diluent for solution for injection. professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
